TrialLipids2011

High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia.

A P Agouridis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.